Vanda Pharmaceuticals Inc (VNDA)


Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Vanda Pharmaceuticals Inc chart...

About the Company

vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

$192M

Total Revenue

346

Employees

$216M

Market Capitalization

29.91

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $VNDA News

Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia

11d ago, source: Zacks.com on MSN

Shares of Vanda Pharmaceuticals Inc. VNDA were down 5.6% on Mar 6 after the company announced that the FDA issued a complete ...

Chairman of Vanda Pharmaceuticals Inc (VNDA) Sells Shares

12d ago, source:

Mihael Polymeropoulos, Chairman of the Board of Vanda Pharmaceuticals Inc (NASDAQ:VNDA), executed a sale of 55,172 shares in ...

Vanda Pharmaceuticals Inc VNDA

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

1mon ago, source: Nasdaq

Corporate Contact: Kevin MoranSenior Vice President, Chief Financial Officer and TreasurerVanda Pharmaceuticals Inc. 202-734-3400 pr@vandapharma.com View original content to download multimedia ...

Vanda Pharmaceuticals (NASDAQ: VNDA)

6d ago, source: The Motley Fool

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis ...

Vanda Pharmaceuticals Receives CRL From FDA On SNDA For HETLIOZ - Quick Facts

12d ago, source:

Vanda Pharmaceuticals Inc. (VNDA) has received a Complete Response Letter from the FDA as part of ongoing review of supplemental New ...

Vanda Pharmaceuticals Inc.

2mon ago, source: CNN

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis ...

Vanda Pharmaceuticals Inc VNDA

11d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Vanda Pharmaceuticals Inc.

6d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...